{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:15:01Z","timestamp":1791994501540,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ygyno.2019.03.251","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T02:26:05Z","timestamp":1553912765000},"page":"505-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment"],"prefix":"10.1016","volume":"153","author":[{"given":"Casey M.","family":"Cosgrove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Rhoades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley S.","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2019.03.251_bb0005","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2019.03.251_bb0010","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/1471-2407-9-460","article-title":"The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study","volume":"9","author":"Seebacher","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2019.03.251_bb0015","doi-asserted-by":"crossref","unstructured":"Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J. Natl. Cancer Inst. 2008;100: 1707\u201316.","DOI":"10.1093\/jnci\/djn397"},{"key":"10.1016\/j.ygyno.2019.03.251_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2019.03.251_bb0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics"},{"key":"10.1016\/j.ygyno.2019.03.251_bb0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2013.10.002","article-title":"Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer","volume":"132","author":"Kumar","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.251_bb0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2014.12.028","article-title":"Robotic transperitoneal infra-renal aortic lymphadenectomy in early-stage endometrial cancer","volume":"136","author":"James","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.251_bb0040","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study","volume":"18","author":"Rossi","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2019.03.251_bb0045","year":"2017"},{"key":"10.1016\/j.ygyno.2019.03.251_bb0050","series-title":"Uterine Neoplasms Version 2","article-title":"NCCN guidelines for treatment of Cancer by site","author":"National Comprehensive Cancer Network","year":"2016"},{"key":"10.1016\/j.ygyno.2019.03.251_bb0055","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch. Surg."},{"key":"10.1016\/j.ygyno.2019.03.251_bb0060","doi-asserted-by":"crossref","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11: 927\u201333.","DOI":"10.1016\/S1470-2045(10)70207-2"},{"key":"10.1016\/j.ygyno.2019.03.251_bb0065","doi-asserted-by":"crossref","unstructured":"Levenback CF, Ali S, Coleman RL, Gold MA, Fowler JM, Judson PL, Bell MC, De Geest K, Spirtos NM, Potkul RK, Leitao MM, Jr., Bakkum-Gamez JN, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J. Clin. Oncol. 2012;30: 3786\u201391.","DOI":"10.1200\/JCO.2011.41.2528"},{"key":"10.1016\/j.ygyno.2019.03.251_bb0070","first-page":"206","article-title":"Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis","volume":"141","author":"Holloway","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.251_bb0075","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ygyno.2017.12.017","article-title":"Sentinel lymph node biopsy in endometrial cancer-feasibility, safety and lymphatic complications","volume":"148","author":"Geppert","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.251_bb0080","doi-asserted-by":"crossref","unstructured":"Schlappe BA, Weaver AL, Ducie JA, Eriksson AGZ, Dowdy SC, Cliby WA, Glaser GE, Soslow RA, Alektiar KM, Makker V, Abu-Rustum NR, Mariani A, et al. Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: a sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy. Gynecol. Oncol. 2018;151: 235\u201342.","DOI":"10.1016\/j.ygyno.2018.08.022"},{"key":"10.1016\/j.ygyno.2019.03.251_bb0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygyno.2018.06.003","article-title":"Lymph node evaluation in high-risk early stage endometrial cancer: a multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy","volume":"150","author":"Buda","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.251_bb0090","doi-asserted-by":"crossref","unstructured":". de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, et al. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncol 2018;19: 295\u2013309.","DOI":"10.1016\/S1470-2045(18)30079-2"},{"key":"10.1016\/j.ygyno.2019.03.251_bb0095","doi-asserted-by":"crossref","unstructured":". Matei D, Filiaci VL, Randall M, Steinhoff M, DiSilvestro P, Moxley KM, et al. A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma. JCO 2017;35(S15):5505.","DOI":"10.1200\/JCO.2017.35.15_suppl.5505"},{"key":"10.1016\/j.ygyno.2019.03.251_bb0100","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(09)62002-X","article-title":"Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis","volume":"375","author":"Todo","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2019.03.251_bb0105","article-title":"Impact of sentinel node approach in gynecologic cancer on training needs","author":"Kumar","year":"2018","journal-title":"J. Minim. Invasive Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581930486X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581930486X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:47:10Z","timestamp":1758772030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581930486X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S009082581930486X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.251","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}